首页 > 最新文献

Zeitschrift fur Gastroenterologie最新文献

英文 中文
[Evidence-based guidelines in gastroenterological medical care: a survey among members of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) on acceptance, application and optimization]. [胃肠病学医疗护理循证指南:德国胃肠、消化和代谢疾病学会(DGVS)成员接受、应用和优化情况调查]。
IF 1.4 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-30 DOI: 10.1055/a-2571-6123
Joschka Bachmann, Pia Lorenz, Lars Klug, Ulrike Denzer, Heiner Wedemeyer, Petra Lynen Jansen

Evidence-based guidelines are an important basis for medical action. The methodological effort to develop guidelines is high. Nevertheless, a high methodological effort in the development of guidelines does not automatically guarantee the success of a guideline, but it must be ensured that guidelines are also accepted and thus applied. Currently (as of October 2024), 28 guidelines are available, which were created under the leadership of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS). How these guidelines are perceived and used in everyday clinical practice and what obstacles exist in their implementation has been little researched so far.This study examines the acceptance and use of the DGVS guidelines with the aim of optimizing the guideline process and implementation.A questionnaire with 32 questions was designed, which included closed questions, Likert scales and free-text answers. The questionnaire was sent by e-mail to 7015 DGVS members. Answering the questionnaire was anonymous and voluntary. In subgroup analyses, physicians in outpatient care, hospitals and university hospitals, as well as physicians with or without experience in guideline development were compared.604 responses were evaluated (response rate 8.6%). The DGVS guidelines are ubiquitously well known and are considered extremely useful by 66% of respondents. They are the main source of information in everyday clinical practice, but their structure is considered to need improvement. Users trust the quality of guidelines regardless of the guideline classification. There are subgroup differences regarding the extent of use or the various reasons for the use of guidelines. In outpatient care, guidelines are more often used to protect oneself against causing a medical error compared to university hospitals, and the avoidance of overtreatment generally seems to be more important at non-university hospitals.Overall, the DGVS guidelines are rated positively. In different areas of medical practice there are different wishes and requirements for guidelines. Improving the topicality of the guidelines is the priority for most respondents. Further starting points for improvement are the structure of the guidelines and focusing on relevant content for everyday cliclinical practice, especially in outpatient care.

循证指南是医疗行动的重要基础。制定指导方针的方法学努力很高。然而,在制定指导方针方面的高度方法论努力并不能自动保证指导方针的成功,但必须确保指导方针也被接受并因此得到应用。目前(截至2024年10月),有28项指南是在德国胃肠病、消化和代谢疾病学会(DGVS)的领导下制定的。这些指南在日常临床实践中是如何被理解和使用的,以及在实施过程中存在哪些障碍,迄今为止几乎没有研究。本研究考察了DGVS指南的接受度和使用情况,旨在优化指南的流程和实施。设计了一份包含32个问题的问卷,其中包括封闭式问题、李克特量表和自由文本答案。问卷通过电子邮件发送给7015名DGVS成员。问卷的回答是匿名和自愿的。在亚组分析中,门诊医生、医院和大学医院的医生以及有或没有指南制定经验的医生进行了比较。共评价604例应答,应答率为8.6%。DGVS指南是众所周知的,66%的受访者认为非常有用。它们是日常临床实践的主要信息来源,但其结构被认为需要改进。无论指南分类如何,用户都信任指南的质量。在使用指南的程度或使用指南的各种原因方面存在亚组差异。在门诊护理中,与大学医院相比,指南更常用于保护自己免受医疗错误的伤害,而在非大学医院,避免过度治疗通常似乎更重要。总体而言,DGVS指南的评价是积极的。在不同的医疗实践领域,对指导方针有不同的愿望和要求。提高指南的时效性是大多数受访者的首要任务。进一步改进的出发点是指南的结构和关注日常临床实践的相关内容,特别是门诊护理。
{"title":"[Evidence-based guidelines in gastroenterological medical care: a survey among members of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) on acceptance, application and optimization].","authors":"Joschka Bachmann, Pia Lorenz, Lars Klug, Ulrike Denzer, Heiner Wedemeyer, Petra Lynen Jansen","doi":"10.1055/a-2571-6123","DOIUrl":"10.1055/a-2571-6123","url":null,"abstract":"<p><p>Evidence-based guidelines are an important basis for medical action. The methodological effort to develop guidelines is high. Nevertheless, a high methodological effort in the development of guidelines does not automatically guarantee the success of a guideline, but it must be ensured that guidelines are also accepted and thus applied. Currently (as of October 2024), 28 guidelines are available, which were created under the leadership of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS). How these guidelines are perceived and used in everyday clinical practice and what obstacles exist in their implementation has been little researched so far.This study examines the acceptance and use of the DGVS guidelines with the aim of optimizing the guideline process and implementation.A questionnaire with 32 questions was designed, which included closed questions, Likert scales and free-text answers. The questionnaire was sent by e-mail to 7015 DGVS members. Answering the questionnaire was anonymous and voluntary. In subgroup analyses, physicians in outpatient care, hospitals and university hospitals, as well as physicians with or without experience in guideline development were compared.604 responses were evaluated (response rate 8.6%). The DGVS guidelines are ubiquitously well known and are considered extremely useful by 66% of respondents. They are the main source of information in everyday clinical practice, but their structure is considered to need improvement. Users trust the quality of guidelines regardless of the guideline classification. There are subgroup differences regarding the extent of use or the various reasons for the use of guidelines. In outpatient care, guidelines are more often used to protect oneself against causing a medical error compared to university hospitals, and the avoidance of overtreatment generally seems to be more important at non-university hospitals.Overall, the DGVS guidelines are rated positively. In different areas of medical practice there are different wishes and requirements for guidelines. Improving the topicality of the guidelines is the priority for most respondents. Further starting points for improvement are the structure of the guidelines and focusing on relevant content for everyday cliclinical practice, especially in outpatient care.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":" ","pages":"571-584"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic findings of Bouveret syndrome. Bouveret综合征的内镜表现。
IF 1.4 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-03-31 DOI: 10.1055/a-2515-3808
Johann von Felden, Julian Schulze Zur Wiesch, Tarik Ghadban, Thomas Rösch, Karsten Ohlhoff

Bouveret syndrome is a rare complication of gallstone disease. We present a 76-year old male patient in whom the diagnosis was complicated by the reporting of coffee-ground emesis suggesting upper gastrointestinal bleeding. Considering the diagnosis of Bouveret syndrome is commonly made through cross-sectional imaging, these patients rarely undergo diagnostic endoscopy. However, this case presented with typical findings during emergency esophagogastroduodenoscopy (EGD) underscoring its educational value for gastroenterologists and endoscopists.

布韦莱特综合征是胆结石疾病的一种罕见并发症。我们报告一位76岁的男性病人,他的诊断因报告咖啡渣呕吐而复杂化,提示上消化道出血。考虑到Bouveret综合征的诊断通常通过横断面成像进行,这些患者很少接受诊断性内窥镜检查。然而,本病例在急诊食管胃十二指肠镜检查(EGD)中表现出典型的结果,强调了其对胃肠病学家和内窥镜医师的教育价值。
{"title":"Endoscopic findings of Bouveret syndrome.","authors":"Johann von Felden, Julian Schulze Zur Wiesch, Tarik Ghadban, Thomas Rösch, Karsten Ohlhoff","doi":"10.1055/a-2515-3808","DOIUrl":"10.1055/a-2515-3808","url":null,"abstract":"<p><p>Bouveret syndrome is a rare complication of gallstone disease. We present a 76-year old male patient in whom the diagnosis was complicated by the reporting of coffee-ground emesis suggesting upper gastrointestinal bleeding. Considering the diagnosis of Bouveret syndrome is commonly made through cross-sectional imaging, these patients rarely undergo diagnostic endoscopy. However, this case presented with typical findings during emergency esophagogastroduodenoscopy (EGD) underscoring its educational value for gastroenterologists and endoscopists.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":" ","pages":"593-595"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Safety and Care After Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP): A Single-Center Experience in Germany. 门诊内窥镜逆行胆管造影(ERCP)后的患者安全和护理:德国的单中心经验。
IF 1.4 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-03-31 DOI: 10.1055/a-2543-3380
Kien Vu Trung, Juergen Feisthammel, Albrecht Hoffmeister, Thomas Karlas

The current goal of adapting care structures in the German healthcare system is to increase the provision of interventional treatments in outpatient settings. Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures were traditionally performed in an inpatient setting until 2022. However, with the introduction of a new Ambulatory Surgery Contract (according to Section 115b, Paragraph 1 of the Social Code, Book V) on January 1, 2023, these procedures are now intended to be carried out more strictly on an outpatient basis, meaning that hospitalization will no longer be reimbursed in most cases.Between June 1, 2023, and December 31, 2023 all ERCP procedures performed in an outpatient setting were included in this study. This cohort had standard ERCP indications and a low comorbidity burden according to the §115b specifications. Using propensity score matching (nearest-neighbor), these cases were matched with patients who underwent ERCP procedures in an inpatient setting between June 1, 2022, and December 31, 2022.Propensity-score matching identified a cohort of 166 patients (83 outpatients and 83 inpatients) with similar baseline characteristics. The most common indications for ERCP were choledocholithiasis and biliary strictures. Reported complications comprised pancreatitis, bleeding and cholangitis and were rare in both groups, occurring in 7% of inpatient procedures and in 6% of outpatient procedures. The latter cases required inpatient admission after self-presenting to the emergency department. No serious adverse events were reported.Outpatient ERCP is a safe procedure for selected patients with a low risk profile. Complications occurred rarely and could be adequately managed.

目前的目标是适应护理结构在德国医疗保健系统是增加提供介入治疗的门诊设置。内镜逆行胆管造影(ERCP)传统上是在住院患者环境中进行的,直到2022年。然而,随着2023年1月1日引入新的门诊手术合同(根据《社会法典》第五卷第115b节第1段),这些手术现在打算更严格地在门诊基础上进行,这意味着在大多数情况下,住院将不再报销。在2023年6月1日至2023年12月31日期间,在门诊环境中进行的所有ERCP手术纳入本研究。根据§115b规范,该队列具有标准的ERCP适应症和低合并症负担。使用倾向评分匹配(最近邻),将这些病例与2022年6月1日至2022年12月31日期间在住院环境中接受ERCP手术的患者进行匹配。倾向评分匹配确定了166例具有相似基线特征的患者(83例门诊患者和83例住院患者)。ERCP最常见的适应症是胆总管结石和胆道狭窄。报告的并发症包括胰腺炎、出血和胆管炎,在两组中都很少见,住院手术的发生率为7%,门诊手术的发生率为6%。后一种情况需要住院后,自我介绍到急诊科。无严重不良事件报告。门诊ERCP对于选定的低风险患者是一种安全的手术。并发症很少发生,可以得到适当的管理。
{"title":"Patient Safety and Care After Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP): A Single-Center Experience in Germany.","authors":"Kien Vu Trung, Juergen Feisthammel, Albrecht Hoffmeister, Thomas Karlas","doi":"10.1055/a-2543-3380","DOIUrl":"10.1055/a-2543-3380","url":null,"abstract":"<p><p>The current goal of adapting care structures in the German healthcare system is to increase the provision of interventional treatments in outpatient settings. Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures were traditionally performed in an inpatient setting until 2022. However, with the introduction of a new Ambulatory Surgery Contract (according to Section 115b, Paragraph 1 of the Social Code, Book V) on January 1, 2023, these procedures are now intended to be carried out more strictly on an outpatient basis, meaning that hospitalization will no longer be reimbursed in most cases.Between June 1, 2023, and December 31, 2023 all ERCP procedures performed in an outpatient setting were included in this study. This cohort had standard ERCP indications and a low comorbidity burden according to the §115b specifications. Using propensity score matching (nearest-neighbor), these cases were matched with patients who underwent ERCP procedures in an inpatient setting between June 1, 2022, and December 31, 2022.Propensity-score matching identified a cohort of 166 patients (83 outpatients and 83 inpatients) with similar baseline characteristics. The most common indications for ERCP were choledocholithiasis and biliary strictures. Reported complications comprised pancreatitis, bleeding and cholangitis and were rare in both groups, occurring in 7% of inpatient procedures and in 6% of outpatient procedures. The latter cases required inpatient admission after self-presenting to the emergency department. No serious adverse events were reported.Outpatient ERCP is a safe procedure for selected patients with a low risk profile. Complications occurred rarely and could be adequately managed.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":" ","pages":"585-592"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutics and (hypothetical) vaccinations against human cryptosporidia]. [针对人类隐孢子虫的治疗方法和(假设的)疫苗]。
IF 1.4 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-29 DOI: 10.1055/a-2551-1670
Yannick Borkens

Cryptosporidium (or cryptosporidiosis caused by them) is one of the most relevant infections of the intestinal tract. The unicellular parasites infect the intestinal cells and cause cramps, weight loss and diarrhea. Cryptosporidia play a special role in AIDS patients. Here they are counted among the diseases that define the acquired immunodeficiency syndrome. Because of this relevance, the search for vaccines is a relevant goal of gastroenterological research. But how realistic are such vaccines? This article describes the disease cryptosporidiosis and reviews current therapeutics and hypothetical vaccine candidates.

隐孢子虫(或由其引起的隐孢子虫病)是与肠道最相关的感染之一。这种单细胞寄生虫会感染肠道细胞,导致痉挛、体重减轻和腹泻。隐孢子虫在艾滋病患者中起着特殊的作用。在这里,它们被列为定义获得性免疫缺陷综合征的疾病。由于这种相关性,寻找疫苗是胃肠病学研究的一个相关目标。但是这种疫苗有多现实呢?本文介绍了隐孢子虫病,并综述了目前的治疗方法和假设的候选疫苗。
{"title":"[Therapeutics and (hypothetical) vaccinations against human cryptosporidia].","authors":"Yannick Borkens","doi":"10.1055/a-2551-1670","DOIUrl":"10.1055/a-2551-1670","url":null,"abstract":"<p><p><i>Cryptosporidium</i> (or cryptosporidiosis caused by them) is one of the most relevant infections of the intestinal tract. The unicellular parasites infect the intestinal cells and cause cramps, weight loss and diarrhea. Cryptosporidia play a special role in AIDS patients. Here they are counted among the diseases that define the acquired immunodeficiency syndrome. Because of this relevance, the search for vaccines is a relevant goal of gastroenterological research. But how realistic are such vaccines? This article describes the disease cryptosporidiosis and reviews current therapeutics and hypothetical vaccine candidates.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":" ","pages":"596-603"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144026542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Well-differentiated Adenocarcinoma Arising from Gastric Cystica Profunda Treated by Endoscopic Submucosal Dissection: A case report and literature review. 内镜下粘膜剥离术治疗胃深囊高分化腺癌1例并文献复习。
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-18 DOI: 10.1055/a-1920-4161
Cao Huang, Jiang Liu

Gastritis cystica profunda (GCP) is a rare disease that is often observed at the stoma site of patients undergoing gastric surgery. Specific symptoms are often lacking, making it difficult to diagnose. GCP may develop into cancer. Endoscopic resection is a good method to reduce surgical injury, and the therapeutic effect depends on the status of the primary disease.The patient was a 77-year-old male who was admitted to the hospital for repeated epigastric distention. The man had never undergone gastric surgery and did not have Helicobacter pylori infection. Physical and laboratory tests showed no abnormality. Computed tomography showed no significant abnormality. Endoscopy revealed multiple ulcers on the posterior wall of the gastric body, but biopsy showed no evidence of malignancy. The patient subsequently underwent ESD surgery with a lesion of 1.5 cm×2.3 cm. Pathological results showed the cystic dilatation of gastric glands in the submucosa, with some well-differentiated adenocarcinoma. The final diagnosis was GCP with well-differentiated gastric adenocarcinoma.Herein, we describe a case of ESD therapy for GCP with well-differentiated gastric adenocarcinoma. When gastric mucosal lesions are difficult to diagnose, further treatment and diagnosis with EMR or ESD can be considered. For patients with early gastric cancer, long-term postoperative monitoring should be carried out.

深囊性胃炎(GCP)是一种罕见的疾病,常见于胃手术患者的造口部位。通常缺乏具体的症状,使其难以诊断。GCP可能发展成癌症。内镜切除是一种减少手术损伤的好方法,治疗效果取决于原发疾病的状态。患者为77岁男性,因反复腹胀入院。该患者从未接受过胃手术,也没有幽门螺杆菌感染。物理和实验室检查均未发现异常。计算机断层扫描未见明显异常。胃镜检查显示胃体后壁有多处溃疡,但活检未见恶性肿瘤。患者随后接受ESD手术,病变面积为1.5 cm×2.3 cm。病理结果显示胃粘膜下层腺体囊性扩张,伴部分高分化腺癌。最终诊断为GCP伴高分化胃腺癌。在此,我们报告一例采用ESD治疗GCP合并高分化胃腺癌的病例。当胃粘膜病变难以诊断时,可考虑进一步治疗并进行EMR或ESD诊断。对于早期胃癌患者,应进行术后长期监测。
{"title":"Well-differentiated Adenocarcinoma Arising from Gastric Cystica Profunda Treated by Endoscopic Submucosal Dissection: A case report and literature review.","authors":"Cao Huang, Jiang Liu","doi":"10.1055/a-1920-4161","DOIUrl":"10.1055/a-1920-4161","url":null,"abstract":"<p><p>Gastritis cystica profunda (GCP) is a rare disease that is often observed at the stoma site of patients undergoing gastric surgery. Specific symptoms are often lacking, making it difficult to diagnose. GCP may develop into cancer. Endoscopic resection is a good method to reduce surgical injury, and the therapeutic effect depends on the status of the primary disease.The patient was a 77-year-old male who was admitted to the hospital for repeated epigastric distention. The man had never undergone gastric surgery and did not have <i>Helicobacter pylori</i> infection. Physical and laboratory tests showed no abnormality. Computed tomography showed no significant abnormality. Endoscopy revealed multiple ulcers on the posterior wall of the gastric body, but biopsy showed no evidence of malignancy. The patient subsequently underwent ESD surgery with a lesion of 1.5 cm×2.3 cm. Pathological results showed the cystic dilatation of gastric glands in the submucosa, with some well-differentiated adenocarcinoma. The final diagnosis was GCP with well-differentiated gastric adenocarcinoma.Herein, we describe a case of ESD therapy for GCP with well-differentiated gastric adenocarcinoma. When gastric mucosal lesions are difficult to diagnose, further treatment and diagnosis with EMR or ESD can be considered. For patients with early gastric cancer, long-term postoperative monitoring should be carried out.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":" ","pages":"497-501"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation and Validation of the German version of FR-QoL-29. 炎症性肠病患者的食物相关生活质量:德语版本FR-QoL-29的翻译和验证
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-31 DOI: 10.1055/a-2542-6781
Lea Pueschel, Katharina Hupa-Breier, Heiner Wedemeyer, Henrike Lenzen, Miriam Wiestler

The psychosocial effects of eating and drinking - summarized as food-related quality of life (FR-QoL) - are underexplored in inflammatory bowel disease (IBD). Currently, there is no German instrument to assess FR-QoL in IBD patients. This study aimed to translate the validated English FR-QoL-29 questionnaire into German and evaluate its validity and reliability.A monocentric, cross-sectional study was conducted at a tertiary referral center with IBD patients and healthy controls. Participants completed questionnaires on sociodemographics, disease history, the Malnutrition Universal Screening Tool (MUST), the German Short Health Scale (SHS), and the FR-QoL-29-German. The FR-QoL-29 was translated into German using a forward-backward method. Its reliability and validity was assessed using Pearson correlation coefficients, intraclass correlation coefficients, and Cronbach's α.N=200 IBD patients (Crohn's disease: 61.8%; women: 50.8%; remission: 56.2%) and n=10 healthy controls completed the questionnaires. Overall, 113 IBD patients repeated the questionnaires after an average of six weeks. Significant differences in FR-QoL-29-German sum scores were found between all levels of IBD disease activity, except for remission - mild disease (p = 0.423) and moderate - severe disease (p = 0.999). FR-QoL-29-German scores significantly correlated with age (p = 0.041), disease activity (p < 0.001), MUST (p = 0.015), fecal Calprotectin (p = 0.011) and SHS (p < 0.001). Overall, the FR-QoL-29-German showed excellent internal consistency (Cronbach's α = 0.965) and good test-retest reliability (ICC = 0.85 [95% CI: 0.78-0.89]).The FR-QoL-29-German is a valid and reliable tool for assessing food-related quality of life in German-speaking individuals with IBD.

饮食对炎症性肠病(IBD)患者的心理社会影响——概括为食物相关生活质量(FR-QoL)——尚未得到充分探讨。目前,没有德国的仪器来评估IBD患者的FR-QoL。本研究旨在将经验证的英文FR-QoL-29问卷翻译成德文,并评估其效度和信度。在IBD患者和健康对照者的三级转诊中心进行了一项单中心、横断面研究。参与者完成了社会人口统计、病史、营养不良普遍筛查工具(MUST)、德国短健康量表(SHS)和德国fr - qol -29问卷调查。FR-QoL-29用正向倒译法翻译成德语。采用Pearson相关系数、类内相关系数和Cronbach’s α评价其信度和效度。200例IBD患者(克罗恩病:61.8%;女性:50.8%;缓解:56.2%)和n=10健康对照完成问卷。总体而言,113名IBD患者在平均6周后重复了问卷调查。除缓解-轻度疾病(p = 0.423)和中度-重度疾病(p = 0.999)外,所有IBD疾病活动性水平的FR-QoL-29-German总分均存在显著差异。FR-QoL-29-German评分与年龄(p = 0.041)、疾病活动性(p < 0.001)、MUST (p = 0.015)、粪便钙保护蛋白(p = 0.011)、SHS (p < 0.001)显著相关。总体而言,FR-QoL-29-German具有良好的内部一致性(Cronbach's α = 0.965)和良好的重测信度(ICC = 0.85 [95% CI: 0.78-0.89])。FR-QoL-29-German是评估德语IBD患者食物相关生活质量的有效和可靠的工具。
{"title":"Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation and Validation of the German version of FR-QoL-29.","authors":"Lea Pueschel, Katharina Hupa-Breier, Heiner Wedemeyer, Henrike Lenzen, Miriam Wiestler","doi":"10.1055/a-2542-6781","DOIUrl":"10.1055/a-2542-6781","url":null,"abstract":"<p><p>The psychosocial effects of eating and drinking - summarized as food-related quality of life (FR-QoL) - are underexplored in inflammatory bowel disease (IBD). Currently, there is no German instrument to assess FR-QoL in IBD patients. This study aimed to translate the validated English FR-QoL-29 questionnaire into German and evaluate its validity and reliability.A monocentric, cross-sectional study was conducted at a tertiary referral center with IBD patients and healthy controls. Participants completed questionnaires on sociodemographics, disease history, the Malnutrition Universal Screening Tool (MUST), the German Short Health Scale (SHS), and the FR-QoL-29-German. The FR-QoL-29 was translated into German using a forward-backward method. Its reliability and validity was assessed using Pearson correlation coefficients, intraclass correlation coefficients, and Cronbach's α.N=200 IBD patients (Crohn's disease: 61.8%; women: 50.8%; remission: 56.2%) and n=10 healthy controls completed the questionnaires. Overall, 113 IBD patients repeated the questionnaires after an average of six weeks. Significant differences in FR-QoL-29-German sum scores were found between all levels of IBD disease activity, except for remission - mild disease (p = 0.423) and moderate - severe disease (p = 0.999). FR-QoL-29-German scores significantly correlated with age (p = 0.041), disease activity (p < 0.001), MUST (p = 0.015), fecal Calprotectin (p = 0.011) and SHS (p < 0.001). Overall, the FR-QoL-29-German showed excellent internal consistency (Cronbach's α = 0.965) and good test-retest reliability (ICC = 0.85 [95% CI: 0.78-0.89]).The FR-QoL-29-German is a valid and reliable tool for assessing food-related quality of life in German-speaking individuals with IBD.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":"63 5","pages":"477-485"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major clinical overlap of the new and former definition of steatotic liver disease in Germany - evidence from the Wuerzburg Fatty Liver Cohort. 德国脂肪变性肝病新定义和旧定义的主要临床重叠-来自维尔茨堡脂肪肝队列的证据
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-05-13 DOI: 10.1055/a-2350-7508
Andreas Geier, Johanna Kestel, Monika Rau
{"title":"Major clinical overlap of the new and former definition of steatotic liver disease in Germany - evidence from the Wuerzburg Fatty Liver Cohort.","authors":"Andreas Geier, Johanna Kestel, Monika Rau","doi":"10.1055/a-2350-7508","DOIUrl":"10.1055/a-2350-7508","url":null,"abstract":"","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":"63 5","pages":"521-523"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R). 不同抗病毒治疗方案对丙型肝炎治愈后长期预后的影响——来自德国丙型肝炎登记处(DHC-R)的数据
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-05-13 DOI: 10.1055/a-2543-5205
Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, Stefan Mauss, Hartwig Klinker, Gerlinde Teuber, Markus Cornberg, Krzysztof Tomasiewicz, Heiner Wedemeyer

Direct-acting antiviral (DAA) regimens for the treatment of hepatitis C virus (HCV) infection are endowed with sustained virological response (SVR) rates >95%. However, HCV cure does not completely eliminate the risk of hepatocellular carcinoma (HCC) development and liver decompensation. The present study investigated the impact of the administered DAA regimen on clinical long-time outcomes after SVR.Matched-pair survival analyses of 5802 chronically HCV infected patients from the German Hepatitis C-Registry compared the incidence of liver-related events 2.5 years after SVR in patients receiving either sofosbuvir (SOF)-based treatment or NS3/NS4A-protease inhibitor (PI)-containing DAA regimens. Hypothesis driven logistic regression analyses were performed to identify independent predictors for the occurrence of liver-related events.Matched-pair survival analyses revealed a borderline significant difference in the incidence of liver-related endpoints (except of HCC development) in patients receiving SOF-based treatment (4.1%) compared to PI-containing DAA regimens (2.6%) 2.5 years after SVR (p=0.061). Numerically, a trend towards a benefit of PI-based DAA treatment was observed (PI 65 events vs SOF 102 events). Hypothesis driven logistic regression analyses could not confirm SOF-based treatment as an independent predictor for the occurrence of liver-related events after HCV cure (p=0.072, OR=0.670).The incidence of liver-related events 2.5 years after HCV cure did not differ significantly between SOF-based DAA treatment and PI-containing regimens. However, numerically a trend towards a benefit of PI-based DAA treatment was observed. Therefore, a minor effect of the applied DAA regimen on the long-term incidence of liver-related events cannot be excluded.

用于治疗丙型肝炎病毒(HCV)感染的直接作用抗病毒(DAA)方案具有持续病毒学应答(SVR)率高达95%。然而,HCV治愈并不能完全消除肝细胞癌(HCC)发展和肝脏失代偿的风险。本研究调查了给予DAA方案对SVR后临床长期结局的影响。来自德国丙型肝炎登记处的5802名慢性HCV感染患者的配对生存分析比较了接受索非布韦(SOF)治疗或含有NS3/ ns4a蛋白酶抑制剂(PI)的DAA方案的患者在SVR后2.5年肝脏相关事件的发生率。采用假设驱动的逻辑回归分析来确定肝脏相关事件发生的独立预测因子。配对生存分析显示,在SVR后2.5年,接受基于sofd治疗的患者的肝脏相关终点(HCC发展除外)的发生率(4.1%)与含pi的DAA方案(2.6%)相比存在临界显著差异(p=0.061)。数值上,观察到基于PI的DAA治疗有获益的趋势(PI 65事件vs sof102事件)。假设驱动的logistic回归分析不能证实基于soff的治疗是HCV治愈后肝脏相关事件发生的独立预测因子(p=0.072, OR=0.670)。HCV治愈2.5年后肝脏相关事件的发生率在基于sofa的DAA治疗和含有pi的治疗方案之间没有显著差异。然而,在数值上观察到以pi为基础的DAA治疗有获益的趋势。因此,不能排除应用DAA方案对肝脏相关事件的长期发生率有轻微影响。
{"title":"Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R).","authors":"Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, Stefan Mauss, Hartwig Klinker, Gerlinde Teuber, Markus Cornberg, Krzysztof Tomasiewicz, Heiner Wedemeyer","doi":"10.1055/a-2543-5205","DOIUrl":"10.1055/a-2543-5205","url":null,"abstract":"<p><p>Direct-acting antiviral (DAA) regimens for the treatment of hepatitis C virus (HCV) infection are endowed with sustained virological response (SVR) rates >95%. However, HCV cure does not completely eliminate the risk of hepatocellular carcinoma (HCC) development and liver decompensation. The present study investigated the impact of the administered DAA regimen on clinical long-time outcomes after SVR.Matched-pair survival analyses of 5802 chronically HCV infected patients from the German Hepatitis C-Registry compared the incidence of liver-related events 2.5 years after SVR in patients receiving either sofosbuvir (SOF)-based treatment or NS3/NS4A-protease inhibitor (PI)-containing DAA regimens. Hypothesis driven logistic regression analyses were performed to identify independent predictors for the occurrence of liver-related events.Matched-pair survival analyses revealed a borderline significant difference in the incidence of liver-related endpoints (except of HCC development) in patients receiving SOF-based treatment (4.1%) compared to PI-containing DAA regimens (2.6%) 2.5 years after SVR (p=0.061). Numerically, a trend towards a benefit of PI-based DAA treatment was observed (PI 65 events vs SOF 102 events). Hypothesis driven logistic regression analyses could not confirm SOF-based treatment as an independent predictor for the occurrence of liver-related events after HCV cure (p=0.072, OR=0.670).The incidence of liver-related events 2.5 years after HCV cure did not differ significantly between SOF-based DAA treatment and PI-containing regimens. However, numerically a trend towards a benefit of PI-based DAA treatment was observed. Therefore, a minor effect of the applied DAA regimen on the long-term incidence of liver-related events cannot be excluded.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":"63 5","pages":"486-496"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Practical guideline for short bowel syndrome]. [短肠综合征的实用指南]。
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-05-13 DOI: 10.1055/a-2375-4601
Stefanie Dabsch, Christian Datz, Clemens Dejaco, Felix Harpain, Elisabeth Hütterer, Ludwig Kramer, Nina Loschko, Alexander Moschen, Anton Stift, Harald Vogelsang

Short bowel syndrome is a rare complex disease that mainly develops due to extensive bowel resections and can lead to chronic intestinal failure. Due to the decreased intestinal surface absorption of macronutrient, micronutrient and/or fluids is reduced. Correspondingly manifold symptoms arise as diarrhoea, weight loss, vitamin deficiencies, chronic kidney disease, hepatopathy and others with great impact on quality of life of patients. Therapy is complex and needs interdisciplinary collaboration between dieticians, gastroenterologists, surgeons and also a dense monitoring of general practitioners. Commonly patients need permanent home-parenteral support. Therapies have to be decided individually and have to be reviewed regularly for effectivity and side effects. Furthermore, periodic monitoring of several clinical and laboratory tests should be performed. Morbidity and mortality of this disease complex is high and lead by appearance and management of complications. This practical guide should give an overview about the disease, diagnostics and management and should enable the best possible care of these complex patients.

短肠综合征是一种罕见的复杂疾病,主要是由于广泛的肠切除术而发展,可导致慢性肠衰竭。由于肠道表面对宏量营养素、微量营养素和/或液体的吸收减少。相应的,会出现腹泻、体重减轻、维生素缺乏、慢性肾病、肝病等多种症状,严重影响患者的生活质量。治疗是复杂的,需要营养师、胃肠病学家、外科医生之间的跨学科合作,也需要对全科医生进行严密的监测。通常患者需要永久性的家庭外肠支持。治疗方法必须单独决定,并且必须定期审查其有效性和副作用。此外,还应定期监测若干临床和实验室检查。这种疾病的发病率和死亡率很高,主要是由于并发症的出现和处理。本实用指南应概述该疾病、诊断和管理,并应使这些复杂患者获得最佳护理。
{"title":"[Practical guideline for short bowel syndrome].","authors":"Stefanie Dabsch, Christian Datz, Clemens Dejaco, Felix Harpain, Elisabeth Hütterer, Ludwig Kramer, Nina Loschko, Alexander Moschen, Anton Stift, Harald Vogelsang","doi":"10.1055/a-2375-4601","DOIUrl":"10.1055/a-2375-4601","url":null,"abstract":"<p><p>Short bowel syndrome is a rare complex disease that mainly develops due to extensive bowel resections and can lead to chronic intestinal failure. Due to the decreased intestinal surface absorption of macronutrient, micronutrient and/or fluids is reduced. Correspondingly manifold symptoms arise as diarrhoea, weight loss, vitamin deficiencies, chronic kidney disease, hepatopathy and others with great impact on quality of life of patients. Therapy is complex and needs interdisciplinary collaboration between dieticians, gastroenterologists, surgeons and also a dense monitoring of general practitioners. Commonly patients need permanent home-parenteral support. Therapies have to be decided individually and have to be reviewed regularly for effectivity and side effects. Furthermore, periodic monitoring of several clinical and laboratory tests should be performed. Morbidity and mortality of this disease complex is high and lead by appearance and management of complications. This practical guide should give an overview about the disease, diagnostics and management and should enable the best possible care of these complex patients.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":"63 5","pages":"502-511"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measurement and Normal Values, Pathologies, Interpretation of findings, and Interventional Ultrasound as part of student ultrasound education. 测量和正常值,病理,结果的解释,介入超声作为学生超声教育的一部分。
IF 1.6 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-01 Epub Date: 2025-05-13 DOI: 10.1055/a-2550-0160
Anna Maria Gschmack, Thomas Karlas, Claudia Lucius, Gregor Barth, Michael Blaivas, Nils Daum, Yi Dong, Adrian Goudie, Beatrice Hoffmann, Christian Jenssen, Michael Kallenbach, Michael Keil, Kathleen Möller, Ricarda Neubauer, Nasenien Nourkami-Tutdibi, Florian Recker, Johannes Peter Ruppert, Roxana Sirli, Johannes Weimer, Susan Campbell Westerway, Constantinos Zervides, Christoph F Dietrich

Ultrasound diagnostics is a widely used, radiation-free, cost-effective, and bedside-applicable imaging technique. Given its numerous advantages and broad application, it appears reasonable to integrate practical use and theory into medical education at an early stage. Since the content of student ultrasound courses varies significantly on an international scale, the aim of this paper is to establish foundations for a more standardized approach to student's ultrasound education (SUSE) especially with focus on abdominal ultrasound. This review examines to what extent measurements can be effectively incorporated into student ultrasound training and under which conditions the teaching of pathologies should be included in these courses. Additionally, the handling of false-positive and false-negative findings in student training is discussed. Considering the growing relevance of interventional ultrasound (INVUS), the paper further explores the extent to which interventional procedures should already be taught during SUSE.

超声诊断是一种应用广泛、无辐射、低成本、床边适用的成像技术。鉴于其众多优点和广泛的应用,在早期阶段将实际应用和理论结合到医学教育中似乎是合理的。由于学生超声课程的内容在国际范围内差异很大,本文的目的是为学生超声教育(SUSE)的更标准化方法奠定基础,特别是腹部超声。这篇综述探讨了在何种程度上测量可以有效地纳入学生超声训练,以及在何种条件下病理学教学应该包括在这些课程中。此外,还讨论了学生训练中假阳性和假阴性结果的处理。考虑到介入超声(INVUS)的相关性日益增强,本文进一步探讨了在SUSE期间应该教授介入程序的程度。
{"title":"Measurement and Normal Values, Pathologies, Interpretation of findings, and Interventional Ultrasound as part of student ultrasound education.","authors":"Anna Maria Gschmack, Thomas Karlas, Claudia Lucius, Gregor Barth, Michael Blaivas, Nils Daum, Yi Dong, Adrian Goudie, Beatrice Hoffmann, Christian Jenssen, Michael Kallenbach, Michael Keil, Kathleen Möller, Ricarda Neubauer, Nasenien Nourkami-Tutdibi, Florian Recker, Johannes Peter Ruppert, Roxana Sirli, Johannes Weimer, Susan Campbell Westerway, Constantinos Zervides, Christoph F Dietrich","doi":"10.1055/a-2550-0160","DOIUrl":"10.1055/a-2550-0160","url":null,"abstract":"<p><p>Ultrasound diagnostics is a widely used, radiation-free, cost-effective, and bedside-applicable imaging technique. Given its numerous advantages and broad application, it appears reasonable to integrate practical use and theory into medical education at an early stage. Since the content of student ultrasound courses varies significantly on an international scale, the aim of this paper is to establish foundations for a more standardized approach to student's ultrasound education (SUSE) especially with focus on abdominal ultrasound. This review examines to what extent measurements can be effectively incorporated into student ultrasound training and under which conditions the teaching of pathologies should be included in these courses. Additionally, the handling of false-positive and false-negative findings in student training is discussed. Considering the growing relevance of interventional ultrasound (INVUS), the paper further explores the extent to which interventional procedures should already be taught during SUSE.</p>","PeriodicalId":23853,"journal":{"name":"Zeitschrift fur Gastroenterologie","volume":"63 5","pages":"513-520"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144016668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zeitschrift fur Gastroenterologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1